Cargando…
Psychosocial Effects of Receiving Genome-Wide Polygenic Risk Information Concerning Type 2 Diabetes and Coronary Heart Disease: A Randomized Controlled Trial
Receiving polygenic risk estimates of future disease through health care or direct-to-consumer companies is expected to become more common in the coming decades. However, only a limited number of studies have examined if such estimates might evoke an adverse psychosocial reaction in receivers. The p...
Autores principales: | Halmesvaara, Otto, Vornanen, Marleena, Kääriäinen, Helena, Perola, Markus, Kristiansson, Kati, Konttinen, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189371/ https://www.ncbi.nlm.nih.gov/pubmed/35706448 http://dx.doi.org/10.3389/fgene.2022.881349 |
Ejemplares similares
-
A Web Portal for Communicating Polygenic Risk Score Results for Health Care Use—The P5 Study
por: Marjonen, Heidi, et al.
Publicado: (2021) -
Diabetes and Cardiovascular Disease Risk Perception and Risk Indicators: a 5-Year Follow-up
por: Vornanen, Marleena, et al.
Publicado: (2020) -
Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk
por: Martikainen, Janne, et al.
Publicado: (2022) -
Genetics in an isolated population like Finland: a different basis for genomic medicine?
por: Kääriäinen, Helena, et al.
Publicado: (2017) -
Editorial: Can population health be personalized? Estonia and Finland as examples
por: Kääriäinen, Helena, et al.
Publicado: (2022)